{"disease":{"id":"renal-impairments","name":"renal impairments"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07241494","title":"Evaluation of Clinical Pharmacy Services and Drug Use in Renal Impairment.","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT07034768","title":"A Study to Evaluate EDG-7500 in People With Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Edgewise Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07445906","title":"A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.","has_results":false},{"nct_id":"NCT05012436","title":"A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Yuhan Corporation","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}